By Josh Boak

President Joe Biden is committing to reduce the cancer death rate by 50% — a new goal for the “moonshot” initiative against the disease that was announced in 2016 when he was vice president.

Biden has set a 25-year timeline for achieving that goal, part of his broader effort to end cancer as we know it, according to senior administration officials who previewed Wednesday's announcement on the condition of anonymity.

The issue is deeply personal for Biden: He lost his elder son, Beau, to brain cancer in 2015.

The pain experienced by the president is shared by many Americans. The American Cancer Society estimates that there will be 1,918,030 new cancer cases and 609,360 cancer deaths this year. What Biden is aiming to do is essentially save more than 300,000 lives annually from the disease, something the administration believes is possible because the age-adjusted death rate has already fallen by roughly 25% over the past two decades. The cancer death rate is currently 146 per 100,000 people, down from nearly 200 in 2000.

The American Cancer Society said in a statement that it applauded Biden for “putting national focus on this critical issue” and that “it will be standing shoulder to shoulder” with the administration.

Dr. Barron Lerner, a professor of medicine and population health at New York University Langone Health, said that “hyperbolic goals" can be needed to attract public attention but achieving the 50% reduction is “extremely unlikely.”

“Similar past efforts like the ‘War on Cancer’ have made gains, but they have been more modest,” said Lerner, the author “The Breast Cancer Wars.” “Cancer is many diseases and requires very complicated research. Translating these advances to the clinical setting is never easy either.”

Biden was scheduled to give remarks Wednesday from the East Room of the White House, along with his wife, Jill, and Vice President Kamala Harris. Also scheduled to attend the speech: members of Congress and the administration and about 100 members of the cancer community including patients, survivors, caregivers, families, advocacy groups and research organizations.

As part of the effort, Biden will assemble a “cancer Cabinet” that includes 18 federal departments, agencies and offices, including leaders from the Departments of Health and Human Services, Veterans Affairs, Defense, Energy and Agriculture.

There were no plans to announce new funding commitments on Wednesday, though the administration will outline why it believes it can curb cancer through efforts such as increased screening and removing inequities in treatment. The coronavirus pandemic has consumed health care resources and caused people to miss more than 9.5 million cancer screenings.

The White House also will host a summit on the cancer initiative and continue a roundtable discussion series on the subject. The goal is to improve the quality of treatment and people’s lives, something with deep economic resonance as well. The National Cancer Institute reported in October that the economic burden of treatment was more than $21 billion in 2019, including $16.22 billion in patient out-of-pocket costs.

President Barack Obama announced the cancer program during his final full year in office and secured $1.8 billion over seven years to fund research. Obama designated Biden, then his vice president, as “mission control," a recognition of Biden's grief as a parent and desire to do something about it. Biden wrote in his memoir “Promise Me, Dad” that he chose not to run for president in 2016 primarily because of Beau's death.

When Biden announced he wasn't seeking the Democratic nomination in 2016, he said he regretted not being president because "I would have wanted to have been the president who ended cancer, because it’s possible.”

The effort fell somewhat out of the public focus when Donald Trump became president, though Trump, a Republican, proposed $500 million over 10 years for pediatric cancer research in his 2019 State of the Union address.

Biden continued the work as a private citizen by establishing the Biden Cancer Initiative to help organize resources to improve cancer care. When Biden did seek the presidency in 2020, he had tears in his eyes as he said in an interview on MSNBC's “Morning Joe" that “Beau should be running for president, not me.”

Share:
More In Politics
U.S. Adds Disappointing 210,000 New Jobs In November
It's a mixed bag for the November jobs report. Hiring slowed last month as employers only added 210,000 jobs, massively missing the estimate of 550,000. But there was one bright spot: the unemployment rate fell to 4.2%, with the number of unemployed people dropping to 6.9 million. Both of those numbers are considerably down from their highs at the end of the 2020 recession. Heather Boushey, a member of President Biden's Council of Economic Advisers, joined Cheddar to discuss the report and the state of the country's ongoing economic recovery.
The State of The U.S. Supply Chain Ahead of the Holiday Season
As the U.S. continues to face supply chain shortages, President Joe Biden is reassuring U.S. consumers that the supply chain is in "very strong shape" ahead of the all-important holiday season. As supply bottlenecks start to show signs of improvement, the industry may be faced with yet another challenge: the Omicron variant. Rob Caucci, Co-Founder & Co-CEO of Fillogic joined Cheddar's Opening Bell to discuss.
Markets Rebound After Friday's Sell-Off
Markets rebounded Monday morning after Friday's deep sell-off that saw the Dow suffer its worse day since 2020. It comes as investors continue to react to the impact of the omicron variant on the broader reopening. Eddie Ghabour, Co-Owner at the Key Advisors Group joined Cheddar's Opening Bell to discuss.
Markets Stage Comeback After Omicron-Driven Sell-Off
Markets bounced back this morning with travel leading the gains after plunging on Monday as the first case of Omicron was detected in the U.S. Jimmy Lee, CEO, Wealth Consulting Group joined Cheddar's Opening Bell to discuss.
Markets See Unrest as Omicron Variant Fears Grow
The market saw investors react to comments by the World Health Organization's chief scientist, who suggested existing vaccines are likely to offer protection against the new variant. According to Thomas Hayes, chairman of Great Hill Capital, the next two weeks will be crucial as the markets watch for not only the effects of the Omicron variant, but also the Fed's decision on a taper.
Possible Omicron Superspreader, Shutdown Averted & Love, Hate, Ate
It's Friday at long last. Jill and Carlo cover the latest on Omicron, including a possible superspreader event in NYC. Plus, previewing the November jobs report, a new Zoom feature no one asked for, and when it's no longer a good idea to eat Thanksgiving leftovers.
Supreme Court Abortion Case Could Impact Midterm Elections
Following the Mississippi abortion case, the fate of Roe V. Wade is at stake. A decision is expected next summer, right around the time midterm candidates will be making their cases to voters. Laura Packard, executive director of Health Care Voter, joins Cheddar News to discuss how the ruling will impact upcoming elections.
Global Markets Impacted By Omicron Fears
Stock markets around the world continue to be impacted by fears of the new Omicron COVID-19 variant. President Biden today reiterated his stance that the new strain is cause for concern, but not cause for panic. Wells Fargo Investment Institute Global Equity Strategist Scott Wren joined Cheddar News' Closing Bell to discuss.
Load More